申请人:Mjalli M. M. Adnan
公开号:US20050096335A1
公开(公告)日:2005-05-05
This invention provides compounds which are useful as inhibitors of protein tyrosine phosphatases (PTPases). As inhibitors of PTPases, the compounds of the invention are useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include type I diabetes, type II diabetes, immune dysfunction, AIDS, autoimmunity, glucose intolerance, obesity, cancer, psoriasis, allergic diseases, infectious diseases, inflammatory diseases, diseases involving the modulated synthesis of growth hormone or the modulated synthesis of growth factors or cytokines which affect the production of growth hormone, or Alzheimer's disease.
本发明提供了可用作蛋白酪氨酸磷酸酶(PTPase)抑制剂的化合物。作为 PTP 酶的抑制剂,本发明的化合物可用于管理、治疗、控制和辅助治疗由 PTP 酶活性介导的疾病。这些疾病包括 I 型糖尿病、II 型糖尿病、免疫功能障碍、艾滋病、自身免疫、葡萄糖不耐受症、肥胖症、癌症、牛皮癣、过敏性疾病、传染性疾病、炎症性疾病、涉及生长激素合成调节或影响生长激素产生的生长因子或细胞因子合成调节的疾病或阿尔茨海默病。